Epic Care-Dublin — Dublin, California

Public research footprint of Epic Care-Dublin, compiled from the ClinicalTrials.gov public registry.

104

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Ovarian Carcinoma · Invasive Breast Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Anatomic Stage IIIA Breast Cancer AJCC v8

Recently updated registry entries

NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT05432791 — Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma… (Active Not Recruiting)
NCT03866382 — Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Epic Care-Dublin?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.